Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE CONSEIL LEVIS : revenue, balance sheet and financial ratios

SELARL PHARMACIE CONSEIL LEVIS is a French company founded 3 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75017), this company of category PME shows in 2024 a net income positive of 79 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE CONSEIL LEVIS (SIREN 948995691)
Indicator 2024
Revenue N/C
Net income 79 029 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2024, SELARL PHARMACIE CONSEIL LEVIS generates positive net income of 79 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

79 029 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 756%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

756.004%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

9.322%

Solvency indicators evolution
SELARL PHARMACIE CONSEIL LEVIS

Sector positioning

Debt ratio
756.0 2024
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELARL PHARMACIE CONSEIL ... (756.00) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
9.32% 2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELARL PHARMACIE CONSEIL ... (9.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of SELARL PHARMACIE CONSEIL LEVIS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE CONSEIL LEVIS is estimated at 1 103 303 € (range 768 322€ - 1 650 604€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
768k€ 1103k€ 1650k€
1 103 303 € Range: 768 322€ - 1 650 604€
NAF 5 année 2024

Valuation method used

Net Income Multiple
79 029 € × 14.0x = 1 103 303 €
Range: 768 323€ - 1 650 605€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE CONSEIL LEVIS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE CONSEIL LEVIS

What is the revenue of SELARL PHARMACIE CONSEIL LEVIS ?

The revenue of SELARL PHARMACIE CONSEIL LEVIS is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE CONSEIL LEVIS profitable?

Yes, SELARL PHARMACIE CONSEIL LEVIS generated a net profit of 79 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE CONSEIL LEVIS ?

The headquarters of SELARL PHARMACIE CONSEIL LEVIS is located in PARIS (75017), in the department Paris.

Where to find the tax return of SELARL PHARMACIE CONSEIL LEVIS ?

The tax return of SELARL PHARMACIE CONSEIL LEVIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE CONSEIL LEVIS operate?

SELARL PHARMACIE CONSEIL LEVIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.